[1] Chládková J,Hak J,Martínková J,et al.High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate. Arzneimittelforschung. 2010;60(12):769-775.
[2] Whitehead VM,Shuster JJ,Vuchich MJ,et al. Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.Leukemia.2005;19(4): 533-536.
[3] van Dalen EC,van As JW,de Camargo B. Methotrexate for high-grade osteosarcoma in children and young adults.Cochrane Database Syst Rev. 2011;(5): CD006325.5.
[4] Perche F, Torchilin VP.Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting.J Drug Deliv. 2013;2013:705265.
[5] Scott AW,Tyler BM,Masi BC,et al.Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model.Biomaterials. 2011; 32(10):2532-2539.
[6] Hami Z,Amini M,Ghazi-Khansari M,et al. Doxorubicin-conjugated PLA-PEG-Folate based polymeric micelle for tumor-targeted delivery: Synthesis and in vitro evaluation. Daru.2014;22:30.
[7] Sriraman SK,Torchilin VP.Recent Advances with Liposomes as Drug Carriers. Advanced Biomaterials and Biodevices.John Wiley & Sons,Inc.2014:79-119.
[8] Dua JS,Rana AC,Bhandari AK.Liposome: classification, preparation, and applications.Int J Pharm Studies Res. 2012;3(2):14-20.
[9] Akbarzadeh A,Rezaei-Sadabady R,Davaran S,et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett.2013;8(1):102.
[10] Milla P,Dosio F,Cattel L.PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery .Curr Drug Metab. 2012;13(1): 105-119.
[11] Jokerst JV,Lobovkina T,Zare RN.Nanoparticle PEGylation for imaging and therapy. Nanomedicine. 2011;6(4):715-728.
[12] 田晨敏,程丽芳,程亮,等.pH敏感白藜芦醇长循环脂质体的制备及其初步体外表征[J].中国新药杂志, 2015,24(11): 1311-1315.
[13] 程晓波,王春玲,苏钰清,等.浊度法与膜材测定法在评价脂质体柱回收率上的对比研究[J].沈阳药科大学学报, 2015,32(2):92-99.
[14] Rogerson A,Cummings J,Florence AT.Adriamycin-loaded niosomes: drug entrapment, stability and release.J Microencapsul.1987;4(4):321-328.
[15] Ruozi B,Belletti D,Tombesi A,et al.AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study. Int J Nanomedicine. 2011;6:557-563.
[16] Dipali SR, Kulkarni SB, Betageri GV.Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods.J Pharm Pharmacol.1996;48(11): 1112-1115.
[17] Fromigué O,Hamidouche Z,Marie PJ.Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.J Biol Chem. 2008; 283(45):30549-30556 .
[18] Hattinger CM,Fanelli M,Tavanti E,et al.Advances in emerging drugs for osteosarcoma.Expert Opin Emerg Drugs.2015;20(3):495-514.
[19] Sterba J,Dusek L,Demlova R,et al.Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: “folate overrescue” concept revisited . Clin Chem. 2006; 52(4):692-700.
[20] Sterba J,Valík D,Bajciova V.High-dose methotrexate in pediatric oncology—back to bench from bedside for a while? J Pediatr Hematol Oncol.2009;31(2):151-152.
[21] Akiyama T,Dass CR,Choong PF.Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway.Mol Cancer Ther.2008;7(11):3461-3469.
[22] Jaffe N,Gorlick R.High-dose methotrexate in osteosarcoma: let the questions surcease-time for final acceptance.J Clin Oncol.2008;26(27):4365-4366.
[23] Mir O,Ropert S,Goldwasser F.Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma.Lancet Oncol.2008;9(12):1198.
[24] Segal E,Pan H,Benayoun L,et al.Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.Biomaterials. 2011; 32(19):4450-4463.
[25] Yang XN,Zeng JC,Song YC,et al.Targeted antiosteosarcoma methotrexate-bisphosphonate conjugate induces apoptosis of osteosarcoma cells in vitro.Eur Rev Med Pharmacol Sci. 2014;18(15): 2116-2123.
[26] Guan XL,Dong Y,Zeng M,et al.Study of sustained- releasing methotrexate combined calcium sulfate in the treatment of osteosarcoma.Shandong Med J.2008. |